• David Weiner, ISV Congress co-Chair

    • Denise Doolan, ISV Congress co-Chair

    • Christiane Gerke, ISV Congress Local co-Chair


    • Peter Anderson, Statens Serum Institut, Denmark
    • Danilo Casimiro, Aeras, USA
    • Ian Frazer, University of Queensland, Australia
    • Nathalie Garcon, Bioaster Technology Research Institute, France
    • Michael Good, Griffith University, Australia
    • Carlos Guzmán, Helmholtz Centre for Infection Research, Germany
    • Adrian Hill, University of Oxford, United Kingdom
    • Peter Hotez, National School of Tropical Medicine, USA
    • Kathrin Jansen, Pfizer, USA
    • Stefan Kaufmann, Max Planck Institute for Infection Biology, Germany
    • Florian Krammer, Icahn School of Medicine at Mount Sinai, USA
    • Marie-Paule Kieny, World Health Organization, Switzerland
    • Jerome Kim, International Vaccine Institute, South Korea
    • Hiroshi Kiyono, University of Tokyo, Japan
    • Gary Kobinger, Centre for Research in Infectious Diseases, Canada
    • Wayne Koff, The Human Vaccines Project, USA
    • Odile Leroy, European Vaccine Initiative, Germany
    • Vish Nene, International Livestock Research Institute, Kenya
    • Stanley Plotkin, University of Pennsylvania, USA
    • Allan Saul, GSK Vaccines Institute for Global Health, Italy
    • Jeffrey Ulmer, GSK Vaccines, USA
    • Tonya Villafana, MedImmune
    • Yu-Mei Wen, Fudan University, China